This cohort study uses data from 2 acute myocardial infarction registries to examine the association of participation in cardiac rehabilitation with health status outcomes after acute myocardial infarction.
This secondary analysis of a randomized clinical trial uses data from SAVOR-TIMI 53 to assess the incremental prognostic value of biomarkers that reflect different pathophysiologic processes in patients with type 2 diabetes.
This prespecified subanalysis of the ENGAGE AF-TIMI 48 trial assesses the use of cardiovascular biomarkers to obtain a risk score in patients with atrial fibrillation.
This prediction model study analysis evaluates performance of an atrial fibrillation risk prediction model using a large repository of electronic medical records.
This study assesses the predictive accuracy of algorithms that use readily available clinical data to identify patients with heart failure while in the hospital.
This cross-sectional study uses data from the National Inpatient Sample database to examine the characteristics of pulmonary arterial hypertension–related hospitalizations.
This study describes the volume and content of Tweets associated with cardiovascular disease, as well as the characteristics of Twitter users.
This serial cross-sectional study of a large cohort of commercially insured patients aged 25 to 64 years examines trends in the rates of cardiac stress testing from 2005 to 2012.
This study investigates genetic differences in 2 pairs of monozygotic twins who had discordant bicuspid-tricuspid aortic valve morphology.
This multicenter survey examines how medical specialists coordinate the complex process of making anticoagulation bridging decisions for certain patients with atrial fibrillation.
This study evaluates results of a quality improvement program to enhance response to ST-segment elevation myocardial infarction in adult inpatients.
This Viewpoint discusses the benefit of treating patients with heart failure with sacubitril/valsartan compared with angiotensin-converting enzyme inhibitors.
This Special Communication presents a view of clinical research centered on measuring and understanding the treatment (“oomph”) effect of interest to enhance understanding of the best use and interpretation of P values and hypothesis tests.
This review addresses the present standard of treatment and survival rates among patients with pulmonary arterial hypertension.
This review examines methods for the identification, prevention, and treatment of cardiovascular complications related to cancer therapy.
A 77-year-old man with a history of mitral valve replacement , previous coronary artery bypass grafting, atrial fibrillation, and heart failure presented to our clinic for evaluation of worsening exertional dyspnea. What is your diagnosis?
Create a personal account or sign in to: